Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Other financing activities (2016 - 2020)

Sonoma Pharmaceuticals (SNOA) has 2 years of Other financing activities data on record, last reported at $39000.0 in Q1 2013.

  • For Q1 2013, Other financing activities changed N/A year-over-year to $39000.0; the TTM value through Mar 2013 reached $39000.0, changed N/A, while the annual FY2020 figure was $50000.0, 261.29% up from the prior year.
  • Other financing activities reached $39000.0 in Q1 2013 per SNOA's latest filing, up from $31000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $39000.0 in Q1 2013 and bottomed at -$31000.0 in Q2 2012.